For example, the observation of downregulation of IL-6 pathways and increased differentiation in dysfunctional EBV-specific CD8+ T cells match with data of an earlier study that found reduced IL-6 signatures and increased differentiation of CAR T cells in CLL patients not responding to CAR therapy.33 This evidence concerns the gene IL6 and B-cell chronic lymphocytic leukemia.